These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30098324)

  • 1. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.
    Villa-Pérez P; Merino B; Fernández-Díaz CM; Cidad P; Lobatón CD; Moreno A; Muturi HT; Ghadieh HE; Najjar SM; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2018 Nov; 88():1-11. PubMed ID: 30098324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
    Abdul-Hay SO; Kang D; McBride M; Li L; Zhao J; Leissring MA
    PLoS One; 2011; 6(6):e20818. PubMed ID: 21695259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice.
    Merino B; Fernández-Díaz CM; Parrado-Fernández C; González-Casimiro CM; Postigo-Casado T; Lobatón CD; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2020 Dec; 113():154352. PubMed ID: 32916153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits.
    Borges DO; Patarrão RS; Ribeiro RT; de Oliveira RM; Duarte N; Belew GD; Martins M; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Raposo JF; Jones JG; Penha-Gonçalves C; Macedo MP
    Metabolism; 2021 May; 118():154735. PubMed ID: 33631143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme.
    Protzek AO; Rezende LF; Costa-Júnior JM; Ferreira SM; Cappelli AP; de Paula FM; de Souza JC; Kurauti MA; Carneiro EM; Rafacho A; Boschero AC
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):1-8. PubMed ID: 26386462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.
    Fernández-Díaz CM; Merino B; López-Acosta JF; Cidad P; de la Fuente MA; Lobatón CD; Moreno A; Leissring MA; Perdomo G; Cózar-Castellano I
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E805-E819. PubMed ID: 31479304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats.
    Taschetto APD; Zimath PL; Silvério R; Dos Santos C; Boschero AC; Dos Santos GJ; Rafacho A
    Life Sci; 2021 Jul; 277():119509. PubMed ID: 33865877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute exercise restores insulin clearance in diet-induced obese mice.
    Kurauti MA; Costa-Júnior JM; Ferreira SM; Dos Santos GJ; Protzek AO; Nardelli TR; de Rezende LF; Boschero AC
    J Endocrinol; 2016 Jun; 229(3):221-32. PubMed ID: 27000684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.
    González-Casimiro CM; Cámara-Torres P; Merino B; Diez-Hermano S; Postigo-Casado T; Leissring MA; Cózar-Castellano I; Perdomo G
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice.
    Rezende LF; Camargo RL; Branco RC; Cappelli AP; Boschero AC; Carneiro EM
    Br J Nutr; 2014 Sep; 112(6):900-7. PubMed ID: 25036874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endurance training inhibits insulin clearance and IDE expression in Swiss mice.
    Costa-Júnior JM; Ferreira SM; Protzek AO; Santos GJ; Cappelli AP; Silveira LR; Zoppi C; de Oliveira CA; Boschero AC; Carneiro EM; Rezende LF
    PLoS One; 2015; 10(3):e0118809. PubMed ID: 25822220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans.
    Fosam A; Sikder S; Abel BS; Tella SH; Walter MF; Mari A; Muniyappa R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1835-46. PubMed ID: 32052016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.
    Kulas JA; Franklin WF; Smith NA; Manocha GD; Puig KL; Nagamoto-Combs K; Hendrix RD; Taglialatela G; Barger SW; Combs CK
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E106-E120. PubMed ID: 30422705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging Reduces Insulin Clearance in Mice.
    Marmentini C; Soares GM; Bronczek GA; Piovan S; Mareze-Costa CE; Carneiro EM; Boschero AC; Kurauti MA
    Front Endocrinol (Lausanne); 2021; 12():679492. PubMed ID: 34054736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Mig-6 in hepatic glucose metabolism.
    Yoo JY; Kim TH; Kong S; Lee JH; Choi W; Kim KS; Kim HJ; Jeong JW; Ku BJ
    J Diabetes; 2016 Jan; 8(1):86-97. PubMed ID: 25594850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
    Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
    Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Calorie Restriction Maintains Plasma Insulin Concentrations along with a Reduction in Hepatic Insulin-Degrading Enzyme Levels in db/db Mice.
    Nonaka Y; Takeda R; Kano Y; Hoshino D
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing.
    Brandimarti P; Costa-Júnior JM; Ferreira SM; Protzek AO; Santos GJ; Carneiro EM; Boschero AC; Rezende LF
    J Endocrinol; 2013 Nov; 219(2):173-82. PubMed ID: 23959080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.